I am assuming Zenith"s AGM will not have a live webcast , would be nice to have some sort of announcement of some sort  exit strategy , or a next level BP partnership, or a buyout or even a 2024 IPO, It amazes me that we have not heard anything good yet that we can vote on at this years AGM,  With all these trials going on can Zenith just hire an investment banker or even a high end consulting firm for an exit stratey. I am certain there is big BP interest.  other Epigenetic biotech with far less clintical trials have been sold in the past few yearsie Constellation pharma . Wake up Don and get your act together or get someone else with market respect to do it!!